(Q43108138)

14 November 2017

Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass (English)

1 reference

14 November 2017

1 reference

10

1 reference

14 November 2017

Matthew G. Cottingham

object named as

Matthew G Cottingham

2

0 references

Alexandra Spencer

object named as

Alexandra J Spencer

7

0 references

Adrian V. S. Hill

12

object named as

Adrian V S Hill

1 reference

14 November 2017

8

Jared D Honeycutt

1 reference

14 November 2017

11

Migena Bregu

1 reference

14 November 2017

3

Christine S Rollier

1 reference

14 November 2017

4

Julie Furze

1 reference

14 November 2017

Robert Alcock

1

1 reference

14 November 2017

Samodh D De Costa

5

1 reference

14 November 2017

Marian Hanlon

6

1 reference

14 November 2017

David H Wyllie

9

1 reference

14 November 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

Science Translational Medicine

14 November 2017

1 reference

14 November 2017

2

1 reference

14 November 2017

19

1 reference

14 November 2017

19ra12

1 reference

Vitrification is essential for anhydrobiosis in an African chironomid, Polypedilum vanderplanki

14 November 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

Trehalose: a review of properties, history of use and human tolerance, and results of multiple safety studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

Trehalose metabolism: from osmoprotection to signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

Adenoviruses as vaccine vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

STEP trial and HIV-1 vaccines inducing T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

Pre-erythrocytic malaria vaccines: towards greater efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

Challenges in the development of an HIV-1 vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

Tuberculosis vaccines: current status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

Tuberculosis vaccine development: goals, immunological design, and evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

Isolation and characterization of protective cytolytic T cells in a rodent malaria model system

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

Effective induction of high-titer antibodies by viral vector vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

Development of formulations that enhance physical stability of viral vectors for gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

Stable liquid vaccines and drugs for the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

Antigen presentation by dendritic cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3000490

10.1126/SCITRANSLMED.3000490

21 January 2018

Identifiers

DOI

1 reference

14 November 2017

1 reference